Our annual white paper is written to provide an industry status of Regulatory Information Management (RIM) containing the current state, key trends, investment focus, projected change, vendor landscape and a perspective of what is 2nd generation RIM. This is based upon several recent large biopharmaceutical benchmark studies, client work, and our insight. RIM continues to [...]
Our annual white paper is written to provide a clear industry status of Regulatory Information Management (RIM) highlighting the current state, key trends and priorities, investment focus, projected capability and organization change, and a comprehensive update on the provider landscape. This year we have an exciting addition that focuses on defining and measuring World Class [...]
Regulatory Information Management (RIM) is clearly transitioning to an enterprise capability with growing connections to other critical functional areas while some potential “game changing” technologies emerge. Our 2016 World Class RIM baseline has now moved to an industry standard based on our 2018 research results and input from 31 contributing companies in our design [...]
Regulatory Information Management (RIM) is one of the highest priority investment areas in Life Sciences R&D today, driven by the need to greatly improve the efficiency of regulatory globally, currently averaging 43% across 18 RIM capabilities[1], and manage regulatory information as a true enterprise asset. In this paper, we will examine why – even now [...]
